• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: Diabetes cost the U.S. $245B in 2012 | MassDevice.com On Call

Report: Diabetes cost the U.S. $245B in 2012 | MassDevice.com On Call

March 7, 2013 By Arezu Sarvestani

MassDevice On Call

MASSDEVICE ON CALL — The cost of diabetes care has increased more than 40% in just 5 years, amounting to $245 billion last year. The growing cost reflects the rising number of patients suffering from the disease, according to a report from the American Diabetes Assn.

More than $1 in every $10 spent on healthcare in the U.S. goes to diabetes and related complications, and more than $2 of every $10 is spent on health complications of a patient that has diabetes, according to a press release.

"As the number of people with diabetes grows, so does the economic burden it places on this country," ADA chief scientific & medical officer Dr. Robert Ratner said in prepared remarks. "It is important to note that while treating diabetes is expensive, it is the fact that the prevalence of the disease is increasing dramatically. Recent estimates project that as many as one in three American adults will have diabetes in 2050."

Key points from the study included:

  • Medical expenditures for people with diabetes are 2.3 times higher than for those without diabetes.
  • The primary driver of increased costs is the increasing prevalence of diabetes in the U.S. population.
  • Despite the introduction of new classes of medication for the treatment of diabetes, anti-diabetic agents and diabetes supplies continue to account for only 12% of medical expenditures in both 2007 and 2012.
  • Most of the cost for diabetes care in the U.S., 62.4 percent, is provided by government insurance (including Medicare, Medicaid and the military). The rest is paid for by private insurance (34.4 percent) or by the uninsured (3.2 percent).
  • Among states, California has the largest population with diabetes and thus the highest costs, at $27.6 billion.  Although Florida’s total population is fourth among states behind California, Texas and New York, it is second in costs at $18.9 billion.

 MIT student wins $30k prize for "cost-appropriate" medical devices
MIT graduate student Nikolai Begg, 25, won the $30,000 Lemelson-MIT prize for his development of a series of medical devices, including a spring-loaded puncture-access system that can retract more quickly than a doctor could.
Read more

 Screening reduces colorectal cancer risk, researchers say
New study results suggest that colonoscopy screening may reduce the incidence of advanced colorectal cancer by as much as 70%, according to researchers from the University of Pennsylvania School of Medicine.  
Read more

 Can weight-loss surgery chase away diabetes?
Weight-loss surgery may beat out "intensive medical therapy" by providing as much as 2 years worth of glycemic control in obese patients with Type II diabetes.
Read more

Filed Under: News Well Tagged With: American Diabetes Assn., On Call

More recent news

  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech
  • China reportedly launches country’s first invasive BCI trial
  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy